Global single-cell technologies market to reach $9.2b by 2029

It is driven by the rising incidence of cancer.

The global single-cell technologies market is projected to reach $9.2b by 2029 at a compound annual growth rate of 17.1%, according to a BCC research study.

It is driven by the rising incidence of cancer, growing demand for personalised medicine, and increasing investment and funding.

The market is segmented by product, cell type, techniques, application, end user, and region.

According to the forecast, the market will be led by consumables (reagents, kits, and assays) and instruments (microscopes, sequencers, and analyzers) under the product segment.

North America holds the highest share whilst several APAC countries are also contributing to its growth.